PURPOSE: To quantify the residual vision in Leber congenital amaurosis (LCA) caused by RPE65 mutations. METHODS: Patients with RPE65-LCA (n = 30; ages, 4-55) were studied using electroretinography (ERG), full-field stimulus testing (FST), kinetic and static threshold perimetry, and optical coherence tomography (OCT). RESULTS: All patients with RPE65-LCA had abnormal ERGs even at the youngest ages. There were no detectable rod ERGs and only reduced cone ERGs. By chromatic FST, however, 59% of patients had measurable rod- and cone-mediated function. The remaining 41% had only cone-mediated function. Extent of kinetic fields varied widely in the first two decades of life but, by the end of the third decade, there was very little measurable field. Regional patterns of visual loss were evident using dark-adapted static threshold perimetry. The mildest dysfunctions showed relatively homogeneous sensitivity loss beyond the central field. Mid-peripheral dysfunction was a later feature; finally, only central and peripheral islands remained. Colocalized measures of visual function and retinal structure by OCT showed that visual function was detectable when a photoreceptor layer was detectable. CONCLUSIONS: Residual rod as well as cone function is detectable in RPE65-LCA. The finding of different regional patterns of visual loss in these patients suggests that the optimal retinal site(s) for subretinal gene delivery to achieve efficacy are likely to change with disease progression.
PURPOSE: To quantify the residual vision in Leber congenital amaurosis (LCA) caused by RPE65 mutations. METHODS:Patients with RPE65-LCA (n = 30; ages, 4-55) were studied using electroretinography (ERG), full-field stimulus testing (FST), kinetic and static threshold perimetry, and optical coherence tomography (OCT). RESULTS: All patients with RPE65-LCA had abnormal ERGs even at the youngest ages. There were no detectable rod ERGs and only reduced cone ERGs. By chromatic FST, however, 59% of patients had measurable rod- and cone-mediated function. The remaining 41% had only cone-mediated function. Extent of kinetic fields varied widely in the first two decades of life but, by the end of the third decade, there was very little measurable field. Regional patterns of visual loss were evident using dark-adapted static threshold perimetry. The mildest dysfunctions showed relatively homogeneous sensitivity loss beyond the central field. Mid-peripheral dysfunction was a later feature; finally, only central and peripheral islands remained. Colocalized measures of visual function and retinal structure by OCT showed that visual function was detectable when a photoreceptor layer was detectable. CONCLUSIONS: Residual rod as well as cone function is detectable in RPE65-LCA. The finding of different regional patterns of visual loss in these patients suggests that the optimal retinal site(s) for subretinal gene delivery to achieve efficacy are likely to change with disease progression.
Authors: S G Jacobson; W J Voigt; J M Parel; P P Apáthy; L Nghiem-Phu; S W Myers; V M Patella Journal: Ophthalmology Date: 1986-12 Impact factor: 12.079
Authors: Samuel G Jacobson; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Alexander Sumaroka; Sharon B Schwartz; Elaine E Smilko; Ann H Milam; Val C Sheffield; Edwin M Stone Journal: Hum Mol Genet Date: 2003-05-01 Impact factor: 6.150
Authors: S G Jacobson; M Buraczynska; A H Milam; C Chen; M Järvaläinen; R Fujita; W Wu; Y Huang; A V Cideciyan; A Swaroop Journal: Invest Ophthalmol Vis Sci Date: 1997-09 Impact factor: 4.799
Authors: Tomas S Aleman; Artur V Cideciyan; Nicholas J Volpe; Giovanni Stevanin; Alexis Brice; Samuel G Jacobson Journal: Exp Eye Res Date: 2002-06 Impact factor: 3.467
Authors: Jie Fan; Baerbel Rohrer; Gennadiy Moiseyev; Jian-Xing Ma; Rosalie K Crouch Journal: Proc Natl Acad Sci U S A Date: 2003-10-24 Impact factor: 11.205
Authors: Samuel G Jacobson; Alexander Sumaroka; Tomas S Aleman; Artur V Cideciyan; Sharon B Schwartz; Alejandro J Roman; Roderick R McInnes; Val C Sheffield; Edwin M Stone; Anand Swaroop; Alan F Wright Journal: Hum Mol Genet Date: 2004-06-30 Impact factor: 6.150
Authors: Nadine S Dejneka; Enrico M Surace; Tomas S Aleman; Artur V Cideciyan; Arkady Lyubarsky; Andrey Savchenko; T Michael Redmond; Waixing Tang; Zhangyong Wei; Tonia S Rex; Ernest Glover; Albert M Maguire; Edward N Pugh; Samuel G Jacobson; Jean Bennett Journal: Mol Ther Date: 2004-02 Impact factor: 11.454
Authors: Vera L Bonilha; Mary E Rayborn; Yong Li; Gregory H Grossman; Eliot L Berson; Joe G Hollyfield Journal: Invest Ophthalmol Vis Sci Date: 2011-10-28 Impact factor: 4.799
Authors: Galuh D N Astuti; Mette Bertelsen; Markus N Preising; Muhammad Ajmal; Birgit Lorenz; Sultana M H Faradz; Raheel Qamar; Rob W J Collin; Thomas Rosenberg; Frans P M Cremers Journal: Eur J Hum Genet Date: 2015-12-02 Impact factor: 4.246
Authors: Michael P Barry; Ava K Bittner; Liancheng Yang; Rebecca Marcus; Mian Haris Iftikhar; Gislin Dagnelie Journal: Optom Vis Sci Date: 2016-07 Impact factor: 1.973
Authors: Samuel G Jacobson; Artur V Cideciyan; Ramakrishna Ratnakaram; Elise Heon; Sharon B Schwartz; Alejandro J Roman; Marc C Peden; Tomas S Aleman; Sanford L Boye; Alexander Sumaroka; Thomas J Conlon; Roberto Calcedo; Ji-Jing Pang; Kirsten E Erger; Melani B Olivares; Cristina L Mullins; Malgorzata Swider; Shalesh Kaushal; William J Feuer; Alessandro Iannaccone; Gerald A Fishman; Edwin M Stone; Barry J Byrne; William W Hauswirth Journal: Arch Ophthalmol Date: 2011-09-12
Authors: Artur V Cideciyan; Geoffrey K Aguirre; Samuel G Jacobson; Omar H Butt; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Sam Sadigh; William W Hauswirth Journal: Invest Ophthalmol Vis Sci Date: 2014-12-23 Impact factor: 4.799
Authors: Samuel G Jacobson; Artur V Cideciyan; Igor V Peshenko; Alexander Sumaroka; Elena V Olshevskaya; Lihui Cao; Sharon B Schwartz; Alejandro J Roman; Melani B Olivares; Sam Sadigh; King-Wai Yau; Elise Heon; Edwin M Stone; Alexander M Dizhoor Journal: Hum Mol Genet Date: 2012-10-03 Impact factor: 6.150
Authors: Lucas Bonafede; Can H Ficicioglu; Leona Serrano; Grace Han; Jessica I W Morgan; Monte D Mills; Brian J Forbes; Stefanie L Davidson; Gil Binenbaum; Paige B Kaplan; Charles W Nichols; Patrick Verloo; Bart P Leroy; Albert M Maguire; Tomas S Aleman Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799